Foundation Medicine Foundation Medicine Test Nabs FDA Approval as CDx for BRAF Inhibitor Therapeutics for Melanoma FoundationOneCDx will also automatically be a companion diagnostic for future BRAF inhibitors approved by the FDA that target specific BRAF mutations. New Products Posted to GenomeWeb: Roche, Jumpcode Genomics, Mikrogen, More People in the News: New Appointments at Grail, Foundation Medicine, Personalis, More Foundation Medicine, Science 37 Partner to Develop Home-Based Clinical Trial Model Foundation will identify patients that may be eligible for clinical trials, and Science 37 will enroll them and provide ongoing support. Foundation Medicine, Epic Ink Deal to Integrate Genomic Tests Into EMR Network The integration is intended to support oncology practices, academic medical centers, and other health systems by providing access to clinical and genomic info. Aug 6, 2021 People in the News: New Appointments at Guardant Health, Foundation Medicine, PGDx, GenapSys, More Jul 16, 2021 FDA Approves Foundation Medicine's Liquid Biopsy Test as CDx for Novartis' Tabrecta in NSCLC Jul 1, 2021 FDA Approves FoundationOne CDx for Takeda's ALK-Inhibitor May 21, 2021 Guardant Health to License IP to Foundation Medicine for $25M, Royalties Under Settlement Agreement Mar 9, 2021 Foundation Medicine, InformedDNA Partner to Expand Genetic Counseling for Cancer Patients Jan 22, 2021 People in the News: New Appointments at Foundation Medicine, Sophia Genetics, Circulogene; More Dec 9, 2020 Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project Nov 18, 2020 Foundation Medicine Licenses Mutation Detection Technology From TwinStrand Biosciences Nov 17, 2020 Diagnostics Firms, Lab Providers Form Genomic Profiling Coalition Nov 9, 2020 FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Lynparza Nov 2, 2020 Regulatory Documents for Newly Approved Liquid Biopsy NGS Panels Detail Diverse Test Claims, Methods Premium Oct 27, 2020 FDA Approves Foundation Medicine Liquid Biopsy Test as CDx for Three Targeted Therapies Oct 26, 2020 FDA Approves Foundation Medicine CDx, Bayer's Vitrakvi for NTRK Patients Sep 18, 2020 Foundation Medicine, Takeda Collaborate to Develop CDx for NSCLC Therapies Sep 16, 2020 Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable Premium Aug 28, 2020 Stakeholders Scramble to Predict Impact of HHS Move Limiting FDA Ability to Regulate LDTs Premium Aug 27, 2020 Foundation Medicine Liquid Biopsy Gets FDA Approval for Multiple Companion Diagnostic Indications Aug 17, 2020 Foundation Medicine, OneOncology Partner to Bring Precision Oncology to Community Practices Aug 5, 2020 TargetCancer Foundation Initiates Precision Medicine Study for Rare Cancers Jul 24, 2020 TMB Harmonization Effort Yields Calibration Method to Correct Inter-Assay Variation Premium Load More Breaking News New Approach Identifies Candidate Causal Variants for Neuropsychiatric, Neurodevelopmental Conditions People in the News: Baylor's Thomas Caskey Dies; New Appointments at UK Biobank, CS Genetics, More In Brief This Week: Pathogenomix, Uniogen, Genetic Technologies, DnaNudge, Gravity Diagnostics, More New Products Posted to GenomeWeb: Biodesix, Curio Genomics, Akoya Biosciences, More NIH Earmarks $170M for All of Us Program's Personalized Nutrition Study Taiwanese Firm's IP Asserted in Suit Against Pacific Biosciences Found Partially Unpatentable The Scan Omicron's Sewage Path The New York Times writes that testing sewage is helping public health officials track Omicron. IBM Sells Part of Watson Health The Wall Street Journal reports IBM is selling part of its Watson Health business to an investment firm. Identifying the Right Whales The Boston Globe writes that genetic testing has helped identify North American right whales and find that weaning can take place earlier than thought. Science Papers on Approach to Quickly Sort Single Cells, Alternative Splicing in Cancer In Science this week: high-speed sorting of single cells using fluorescence imaging, and more.